[Durgical](https://durgical.com/en/) › [DurgiPedia](https://durgical.com/en/durgipedia/) › [Pharmacology](https://durgical.com/en/pharmacology/) › [Dopamine agonists](https://durgical.com/en/pharmacology/classes/dopamine-agonists/) › Pramipexole

[Pharmacology](https://durgical.com/en/pharmacology/) · [Dopamine agonists](https://durgical.com/en/pharmacology/classes/dopamine-agonists/)

# Pramipexole

A non-ergot dopamine agonist for Parkinson disease and restless legs. Known for sudden sleep attacks and impulse-control disorders.

Updated 2026-11-01

- Class: [Dopamine agonists](https://durgical.com/en/pharmacology/classes/dopamine-agonists/)
- Receptor: Dopamine D3 and D2 receptors (D3 shown)
- ATC code: N04BC05

◎**Dopamine D3 and D2 receptors (D3 shown)**Pramipexole

ⓘ The figure shows pramipexole bound to the human D3 receptor coupled to its Gi protein.

**Target in 3D:** Dopamine D3 and D2 receptors (D3 shown). PDB structure 7CMU (RCSB PDB, public domain). [View the structure at RCSB PDB](https://www.rcsb.org/structure/7CMU) · Drag to rotate · pinch to zoom

## Mechanism of action

Pramipexole stimulates D2-family dopamine receptors directly, with higher affinity for D3 than for D2 or D4. Because it acts on the receptor, it works even when few dopamine neurons remain.

- Pramipexole binds D3 and D2 receptors in the striatum
- It mimics dopamine without needing dopamine neurons
- Movement circuits are activated again
- Slowness and rigidity improve; restless legs settle

## Pharmacokinetics

**Absorption**
Rapidly absorbed; oral bioavailability above 90%

**Elimination**
About 90% recovered in urine, almost all unchanged; the dose is adjusted in kidney disease

**Half-life**
About 8 hours in young adults and about 12 hours in older adults

## Indications

- Parkinson disease, alone or with levodopa [Parkinson disease →](https://durgical.com/en/conditions/parkinson-disease/)
- Moderate to severe primary restless legs syndrome [Restless legs syndrome →](https://durgical.com/en/conditions/restless-legs-syndrome/)

## Adverse effects

### Common

- Nausea, dizziness, somnolence
- Dyskinesia when added to levodopa
- Orthostatic hypotension, mainly when the dose is raised
- Dry mouth and leg swelling

### Serious (rare, important)

- Falling asleep without warning during daily activities, including driving
- Impulse-control and compulsive behaviours (gambling, sex, spending, binge eating)
- Hallucinations and psychotic-like behaviour
- Augmentation and rebound in restless legs syndrome
- Withdrawal symptoms or hyperpyrexia and confusion after sudden stopping

## Contraindications

- No absolute contraindications on the label; caution in kidney disease, psychosis and in people who drive

## Key interactions

**Antipsychotics, metoclopramide**
Dopamine antagonists reduce its effect

**Cimetidine and other drugs secreted by the kidney**
Raise pramipexole levels and sleepiness

**Alcohol and sedatives**
More somnolence and sleep attacks

## What is monitored

- Daytime sleepiness and episodes of falling asleep
- New gambling, sexual, spending or eating urges (ask the family too)
- Standing blood pressure
- Kidney function

## Administration and safety

- Increased gradually and, when stopped, tapered rather than stopped suddenly
- Immediate-release and extended-release tablets are different products
- Taking it with food can reduce nausea

## Nursing care

- Teach not to drive until sleepiness is known, and to report sudden sleep
- Ask patient and family about gambling, shopping or sexual behaviour changes
- Check orthostatic blood pressure and fall risk
- Report hallucinations or confusion

## Pregnancy and breastfeeding

Animal studies suggest possible harm to the fetus; there are no adequate human data.

## Memory aid

«Pramipexole: Pee it out, Pass out, Play cards»: cleared by the kidney, sudden sleep attacks and gambling urges.

## Test yourself

Think of the answer, then tap the question to see it.

## Which dopamine receptor subtype does pramipexole bind with highest affinity?

D3, more than D2 or D4.

## How is pramipexole mainly eliminated?

Unchanged in the urine, so the dose is adjusted in kidney disease.

## Which two adverse effects of pramipexole matter for driving and for family finances?

Sudden sleep attacks and impulse-control disorders such as pathological gambling or compulsive spending.

## Besides Parkinson disease, which disorder is pramipexole approved for?

Moderate to severe primary restless legs syndrome.

[Add to my cards (4)](https://durgical.app/estudiar/?add=/en/pharmacology/pramipexole/)

## Related drugs

- [Ropinirole](https://durgical.com/en/pharmacology/ropinirole/)
- [Levodopa + carbidopa](https://durgical.com/en/pharmacology/levodopa-carbidopa/)
- [Cabergoline](https://durgical.com/en/pharmacology/cabergoline/)

## Related conditions

- [Parkinson disease](https://durgical.com/en/conditions/parkinson-disease/)
- [Restless legs syndrome](https://durgical.com/en/conditions/restless-legs-syndrome/)

[← Back to the class: Dopamine agonists](https://durgical.com/en/pharmacology/classes/dopamine-agonists/)

Educational content on how drugs work; not a prescribing guide and no substitute for a health professional's advice. No doses are given.

Sources: [DailyMed - PRAMIPEXOLE DIHYDROCHLORIDE tablet](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fb2260d6-204c-4d25-a331-0f8340d83a6e) (DailyMed (U.S. National Library of Medicine), 2026); [Pramipexole: MedlinePlus Drug Information](https://medlineplus.gov/druginfo/meds/a697029.html) (MedlinePlus (U.S. National Library of Medicine), 2022); Goodman & Gilman's The Pharmacological Basis of Therapeutics, 14th ed., ch. 21 (McGraw Hill, 2023).

## **Spotted a mistake?** We are always improving for the community. Tell us what is wrong and our team will review it. Report a mistake

Representative model, for educational purposes only.

---
Source: https://durgical.com/en/pharmacology/pramipexole/
License: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Cite as: DurgiPedia (durgical.com), https://durgical.com/en/pharmacology/pramipexole/
